Amaryllis Nucleics is a University of California-Davis spinoff that aims to revolutionize RNA sequencing for researchers worldwide. With 36 years of experience in molecular biology and bioinformatics, the founders have developed a groundbreaking approach to RNA-seq library synthesis. By leveraging the natural process of DNA breathing, they have eliminated multiple steps, significantly reducing the time and cost of library synthesis.

Their innovative technology has been published in the respected journal Frontiers. Amaryllis Nucleics is driven by the mission to democratize RNA sequencing and promote open science. They provide an end-to-end service, offering not only their cutting-edge technology but also their expertise in molecular biology and bioinformatics.

Their team, led by CEO Dr. Brad Townsley and CTO Dr. Mike Covington, is dedicated to empowering scientists to make important innovations.

Amaryllis Nucleics is now a part of Active Motif, located in Carlsbad, CA. Reach out to them to request a quote and learn more about their game-changing solutions